.Attribute Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for introduction of people along with MASLD as well as size of liver outcomes in cardio-- renal-- metabolic trials, when records advise mechanistically plausible benefits and also scientific safety and security-- and lays out factors for test style and regulative commendation.